Price T Rowe Associates Inc Tandem Diabetes Care Inc Transaction History

Price T Rowe Associates Inc

$836 Billion
Q2 2024

A detailed history of Price T Rowe Associates Inc transactions in Tandem Diabetes Care Inc stock. As of the latest transaction made, Price T Rowe Associates Inc holds 44,791 shares of TNDM stock, worth $1.9 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

44,791

Previous 38,732 15.64%

Holding current value

$1.9 Million

Previous $1.37 Million 31.56%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$30.43 - $53.43 $184,375 - $323,732	6,059 Added 15.64%	44,791 $1.81 Million
Q1 2024 May 15, 2024	BUY	$22.09 - $35.41 $43,848 - $70,288	1,985 Added 5.4%	38,732 $1.37 Million
Q4 2023 Feb 14, 2024	BUY	$14.28 - $31.03 $27,574 - $59,918	1,931 Added 5.55%	36,747 $1.09 Million
Q3 2023 Nov 14, 2023	BUY	$19.33 - $36.22 $53,872 - $100,945	2,787 Added 8.7%	34,816 $724,000
Q2 2023 Aug 14, 2023	SELL	$24.18 - $42.46 $6.27 Million - $11 Million	-259,162 Reduced 89.0%	32,029 $786,000
Q1 2023 May 15, 2023	BUY	$35.86 - $46.5 $33,170 - $43,012	925 Added 0.32%	291,191 $11.8 Million
Q4 2022 Feb 14, 2023	SELL	$35.49 - $56.15 $4.03 Million - $6.38 Million	-113,679 Reduced 28.14%	290,266 $13 Million
Q3 2022 Nov 14, 2022	SELL	$43.76 - $68.97 $10.1 Million - $16 Million	-231,499 Reduced 36.43%	403,945 $19.3 Million
Q2 2022 Aug 15, 2022	BUY	$53.22 - $123.09 $412,295 - $953,578	7,747 Added 1.23%	635,444 $37.6 Million
Q1 2022 May 16, 2022	BUY	$101.89 - $150.09 $395,944 - $583,249	3,886 Added 0.62%	627,697 $73 Million
Q4 2021 Feb 14, 2022	SELL	$118.18 - $153.21 $3.13 Million - $4.06 Million	-26,494 Reduced 4.07%	623,811 $93.9 Million
Q3 2021 Nov 15, 2021	SELL	$93.51 - $129.4 $12.3 Million - $17 Million	-131,038 Reduced 16.77%	650,305 $77.6 Million
Q2 2021 Aug 16, 2021	SELL	$77.0 - $100.19 $24.1 Million - $31.4 Million	-312,972 Reduced 28.6%	781,343 $76.1 Million
Q1 2021 May 17, 2021	SELL	$81.28 - $104.34 $22.5 Million - $28.9 Million	-277,065 Reduced 20.2%	1,094,315 $96.6 Million
Q4 2020 Feb 16, 2021	BUY	$86.4 - $121.75 $118 Million - $167 Million	1,371,380 New	1,371,380 $131 Million

Others Institutions Holding TNDM

# of Institutions

344

Shares Held

72.7M

Call Options Held

3.12M

Put Options Held

343K

View Full List

About TANDEM DIABETES CARE INC

Ticker TNDM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 64,221,200
Market Cap $2.72B
Description
Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin c...

More about TNDM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Account

Price T Rowe Associates Inc Tandem Diabetes Care Inc Transaction History